Showing results (241-250 of 462) with videos related to
Sort By:
Pageof 47
Central Nervous System Agents in Medicinal Chemistry|July 24, 2015
Computational Analysis and Functional Prediction of Ubiquitin Hypothetical Protein: A Possible Target in Parkinson DiseaseLaline Barragan-Osorio, Gustavo Giraldo, Carlos J Almeciga-Diaz, et al.Central Nervous System Agents in Medicinal Chemistry|July 11, 2015
Old Weapons for New Wars: Bioactive Molecules From Cnidarian Internal Defense SystemsTrapani M Rosa, Parisi M Giovanna, Maisano Maria, et al.Central Nervous System Agents in Medicinal Chemistry|October 19, 2018
A Novel Non-invasive Effective Method for Potential Treatment of Degenerative Disc Disease: A HypothesisSiva G Somasundaram, Cristian Muresanu, Pamela Schield, et al.Central Nervous System Agents in Medicinal Chemistry|June 12, 2018
Neuropharmacological Profile of Gamma-Decanolactone on Chemically-induced Seizure in MicePricila Pfluger, Vanessa Rodrigues Coelho, Gabriela Gregory Regner, et al.Central Nervous System Agents in Medicinal Chemistry|August 24, 2016
Cholinergic System and Neuroinflammation: Implication in Multiple SclerosisMaria Di Bari, Giovanni Di Pinto, Marcella Reale, et al.Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's diseaseSadayuki Hashioka, Patrick L McGeer, Akira Monji, et al.Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Neuroleptics and migrainePetcharat Dusitanond, William B YoungCentral Nervous System Agents in Medicinal Chemistry|December 22, 2009
The insulin-like growth factor-1 axis and its potential as a therapeutic target in central nervous system (CNS) disordersOlivia Bibollet-Bahena, Qiao-Ling Cui, Guillermina AlmazanCentral Nervous System Agents in Medicinal Chemistry|December 22, 2009
Biochemistry and neurobiology of prosaposin: a potential therapeutic neuro-effectorRoberta Misasi, Isao Hozumi, Takashi Inuzuka, et al.Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic painJosé Luis Díaz, Daniel Zamanillo, Jordi Corbera, et al.Pageof 47